European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease: BioArctic Read more
CytomX Therapeutics Announces Milestone Achievement in Probody T-Cell Engaging Bispecific (TCB) Collaboration with Astellas Read more
FDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease Read more
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy Read more
Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor Read more
Sandoz announces agreement to acquire leading antifungal agent Mycamine from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio Read more
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso Read more